MESO Stock Analysis: Buy, Sell, or Hold?
MESO - Mesoblast Limited American Depositary Shares
$17.25
-0.71 (-3.95%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When MESO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MESO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MESO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: MESO is currently trading at $17.25, which is considered oversold relative to its 30-day fair value range of $17.61 to $19.41. The stock's valuation (Forward PE: 224.5) is in line with its historical norms (231.0). Remarkably, the market is currently pricing in an annual earnings decline of 1.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MESO is in a uptrend. Immediate support is located at $16.67, while resistance sits at $19.34. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $35.00 (+94.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MESO is in a uptrend. Immediate support is located at $16.67, while resistance sits at $19.34. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $35.00 (+94.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$17.61 -
$19.41
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.6%
Protect Your Profits
Holding MESO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 94.9% below Wall St target ($35.00)
- CAUTION: Recommendation downgraded due to -6.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$17.61 -
$19.41
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.92
(11.1%)
Support & Resistance Levels
Support Level
$16.67
Resistance Level
$19.34
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
224.50
Wall Street Target
$35.00
(+94.9%)
Revenue Growth (YoY)
458.6%
Valuation Discount vs History
-1.0% cheaper
PE vs Historical
224.5 vs 231.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.0%
(market-implied from PE analysis)
1-Year Target
$17.78
(-1%)
2-Year Target
$17.60
(-2%)
3-Year Target
$17.43
(-3%)
3-Yr Target (if PE normalizes)
(PE: 225→231)
$17.93
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 224.5 to 231.0
Stabilization Target:
$18.48
(+2.9%)
PE Expansion Potential:
+2.9%
Last updated: January 31, 2026 5:56 AM ET
Data refreshes hourly during market hours. Next update: 6:56 AM
Data refreshes hourly during market hours. Next update: 6:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MESO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced MESO Option Strategies
Professional options setups generated by AI based on today's MESO price and gamma walls.
